Surface Oncology Inc

NASDAQ:SURF   3:59:54 PM EDT
1.78
+0.03 (+1.71%)
Earnings Announcements

Surface Oncology Reports Financial Results And Corporate Highlights For First Quarter 2022

Published: 05/09/2022 13:46 GMT
Surface Oncology Inc (SURF) - Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2022.
Cash Runway Extended Into 2024.
Expanding Open Label Lead-in for Srf388 in First-line Hcc, With Initial Data Expected in First Half of 2023.
Qtrly Earnings per Share $0.13.
Q1 Earnings per Share View $-0.29 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $6.58 Million
Adjusted EPS is expected to be -$0.45

Next Quarter Revenue Guidance is expected to be $0.58 Million
Next Quarter EPS Guidance is expected to be -$0.47

More details on our Analysts Page.